Zentalis Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Zentalis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Zentalis Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Zentalis Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.4M | 93k | 15.15 |
| 2023-09-30 | $2.0M | 102k | 20.06 |
| 2023-06-30 | $3.1M | 111k | 28.21 |
| 2023-03-31 | $1.0M | 61k | 17.20 |
| 2022-12-31 | $943k | 47k | 20.13 |
| 2022-06-30 | $1.6M | 57k | 28.09 |
| 2022-03-31 | $8.8M | 106k | 83.33 |
| 2021-12-31 | $2.3M | 28k | 84.13 |
| 2021-03-31 | $606k | 14k | 43.33 |
| 2020-12-31 | $703k | 14k | 52.13 |
| 2020-09-30 | $144k | 4.3k | 33.51 |
| 2020-06-30 | $167k | 3.5k | 48.03 |